Hypericin
Hypericin inhibits RANKL-mediated osteoclastogenesis via affecting ERK signalling in vitro and suppresses wear particle-induced osteolysis in vivo.
Product Specifications
CAS Number
548-04-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
504.45
Molecular Formula
C30H16O8
Notes
Research use only, not for human use.
Receptor
Antibacterial|antiviral
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6294351-01 0.1 mL
EDG2, NT (LPAR1, EDG2, LPA1, Lysophosphatidic acid receptor 1, Lysophosphatidic acid receptor Edg-2) (MaxLight 405)
Ask
View Details 
MBS6294351-02 5x 0.1 mL
EDG2, NT (LPAR1, EDG2, LPA1, Lysophosphatidic acid receptor 1, Lysophosphatidic acid receptor Edg-2) (MaxLight 405)
Ask
View Details